Principal Financial Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Sell |
203,836
-5,000
| -2% | -$69.9K | ﹤0.01% | 1734 |
|
|
2025
Q1 | $2.82M | Buy |
208,836
+30,392
| +17% | +$410K | ﹤0.01% | 1704 |
|
|
2024
Q4 | $3.42M | Buy |
178,444
+5,634
| +3% | +$108K | ﹤0.01% | 1692 |
|
|
2024
Q3 | $3.93M | Buy |
172,810
+162,665
| +1,603% | +$3.7M | ﹤0.01% | 1634 |
|
|
2024
Q2 | $132K | Sell |
10,145
-1,770
| -15% | -$23K | ﹤0.01% | 2198 |
|
|
2024
Q1 | $209K | Buy |
11,915
+1,058
| +10% | +$18.5K | ﹤0.01% | 2169 |
|
|
2023
Q4 | $236K | Sell |
10,857
-199
| -2% | -$4.33K | ﹤0.01% | 2120 |
|
|
2023
Q3 | $170K | Buy |
11,056
+222
| +2% | +$3.41K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $258K | Buy |
10,834
+819
| +8% | +$19.5K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $255K | Sell |
10,015
-114
| -1% | -$2.9K | ﹤0.01% | 2127 |
|
|
2022
Q4 | $296K | Buy |
+10,129
| New | +$296K | ﹤0.01% | 2102 |
|